Zenas BioPharma CEO Executes $1.07 Million Stock Purchase Amid Recent Price Volatility
Leon O. Moulder Jr., the Chief Executive Officer and Director of Zenas BioPharma, Inc. (NASDAQ: ZBIO), has completed a significant acquisition of company common stock valued at approximately $1,067,200. The transactions took place over a two-day period in late April 2026, with share prices fluctuating between $17.56 and $18.05. This insider activit…